Cargando…
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia, bipolar disorders and other psychotic disorders. However, they might cause metabolic syndrome (MetS) in terms of weight gain, dyslipidemia, type 2 diabetes (T2D), and high blood pressure, which are responsible...
Autores principales: | Carli, Marco, Kolachalam, Shivakumar, Longoni, Biancamaria, Pintaudi, Anna, Baldini, Marco, Aringhieri, Stefano, Fasciani, Irene, Annibale, Paolo, Maggio, Roberto, Scarselli, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001502/ https://www.ncbi.nlm.nih.gov/pubmed/33800403 http://dx.doi.org/10.3390/ph14030238 |
Ejemplares similares
-
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
por: Carli, Marco, et al.
Publicado: (2021) -
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics
por: Carli, Marco, et al.
Publicado: (2023) -
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center
por: Carli, Marco, et al.
Publicado: (2022) -
Dopamine D(2) Receptors Dimers: How can we Pharmacologically Target Them?
por: Carli, Marco, et al.
Publicado: (2018) -
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
por: Barachini, Serena, et al.
Publicado: (2023)